ABUNDIA GLOBAL IMPACT GROUP, INC. financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data ABUNDIA GLOBAL IMPACT GROUP, INC. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue		0.63	2.36	1	0.55	1.33	1.64	0.79	0.56	0.41
Research and development									1.65	0.75
General and administrative	1.69	2.13	1.42	1.36	1.45	1.49	1.58	1.85	2.44	10.6
Operating expenses	2.81	2.51	2.69	3.33	4.74	2.36	2.42	5.37	8.05	29.2
Operating income	-2.65	-1.88	-0.34	-2.33	-4.18	-1.03	-0.78	-4.58	-8.05	-28.7
Interest expense		0.17		0.18	0.03	0			0.4	0.4
Interest income	0.01	0	0	0	0.01	0.01	0.03	0.15	0.24	0.03
Other non-operating income	0.01	-0.16	0.09	-0.18	0.15	0.01	0.03	1.37	4.43	-0.71
Pre-tax income	-2.64	-2.04	-0.25	-2.52	-4.04	1.02	-0.74	-3.21	-3.62	-29.5
Net income to minority interests									-0.01	-0.01
Net income	-2.64	-2.04	-0.25	-2.52	-4.04	-1.02	-0.74	-3.21	-3.61	-29.5
EBITDA	-2.35	-1.71	0.02	-1.9	-3.82	-0.79	-0.57	-4.41	-8.03	-28.5
EPS, basic	-0.01	-0.01	-0.00	-0.08	-0.09	-0.02	0.01	-0.05	-0.11	-0.90
EPS, diluted	-0.01	-0.01	-0.00	-0.08	-0.09	-0.02	0.01	-0.05	-0.11	-0.90
Shares, basic (weighted)	342	358	402	35	46.1	64.2	66.1	71.6	31.8	32.8
Shares, diluted (weighted)	342	358	402	35	46.1	64.2	66.1	71.6	31.8	32.8

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	0.48	0.39	0.76	0.1	1.24	4.89	4.55	4.06	0.53	4.79
Receivables		0.35	0.14	0.08	0.1	0.21	0.16	0.07	0.08	0.51
Other current assets	0	0	0.07	0.04	0.04	0.09	0.08	0.04	0.12	0.18
Total current assets	0.48	0.74	0.96	0.22	1.37	5.19	4.8	4.17	0.85	6.29
Property, plant and equipment	2.46	6.81	6.86	6.37	5.01	4.81	4.62	1.56	0	11.3
Lease right-of-use assets				0.28	0.19	0.27	0.21	0.15	0.07	0.15
Goodwill										13.2
Intangible assets										1.4
Other non-current assets	0	0	0	0	0	0	0	0	0	0.01
Total assets	2.95	7.56	7.82	7.07	6.84	10.7	11.7	10.4	4.11	34.3
Accounts payable	0.05	0.13	0.06	0.27	0.12	0.07	0.11	0.16	0.28	2.72
Accrued liabilities	0.01	0.02	0	0	0	0.02	0.02	0.02	0.02
Short-term debt									5.86
Total current liabilities	0.06	0.15	0.06	0.97	0.23	0.14	0.2	0.25	6.19	7.31
Lease liabilities				0.22	0.11	0.21	0.15	0.07		0.15
Total liabilities	0.09	0.24	0.15	1.23	0.4	0.42	0.41	0.38	6.19	13.8
Total debt										10.2
Paid-in capital	66.2	72.5	73.1	73.9	78.5	83.3	85.1	87	14.6	65
Retained earnings	-63.2	-65.2	-65.5	-68	-72	-73	-73.8	-77	-16.6	-47.7
Treasury stock	-0.17
Other comprehensive income									-0.07	-0.01
Shareholders' equity	2.86	7.32	7.68	5.84	6.44	10.3	11.3	10	-2.08
Total equity	2.86	7.32	7.68	5.84	6.44	10.3	11.3	-0.84	-2.08	20.6
Total liabilities and equity	2.95	7.56	7.82	7.07	6.84	10.7	11.7	10.4	4.11	34.3
Shares outstanding	346	393	414	35	46.3	65.9	68.5	72.4	31.8	36.9

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	-2.64	-2.04	-0.25	-2.52	-4.04	-1.02	-0.74	-3.21	-3.62	-29.5
Depreciation and amortization	0.3	0.16	0.36	0.44	0.36	0.25	0.21	0.17	0.02	0.21
Stock-based compensation	0.14	0.31	0.1	0.16	0.43	0.32	0.21	0.24	0.1	1.52
Deferred income tax		7.95
Change in receivables		-0.35	0.21	0.06	-0.02	-0.12	0.05	0.09	-0	-0.02
Change in payables	0.02	-0.01	0.01	0.31	-0.14	-0.09	0.05	0.04	-0.01	0.42
Cash from operations	-1.3	-1.72	0.36	-0.73	-0.86	-0.68	-0.23	0.26	-1.92	-8.05
Capital expenditures										-8.66
Purchases of investments				-0.2	-0.06	-0.2	-1.65	-2.4	-1.89
Cash from investing	-0.21	-4.41	-0.51	-0.89	-1.57	-0.24	-1.66	-2.4	-0.32	-3.1
Stock issued		4.1	0.75	0.61	4.43	6.58	1.54	1.65	2.33
Share buybacks	-0.14
Dividends paid		-0.14	-0.24	-0.23	-0.23	-0.04
Cash from financing	-0.14	6.04	0.51	0.97	3.58	4.57	1.54	1.65	2.4	15.2
Exchange rate effect									-0.02	0.06
Net change in cash	-1.64	-0.09	0.36	-0.66	1.14	3.65	-0.35	-0.49	0.14	4.09
Free cash flow										-16.7
Interest paid		0.01		0.02	0					0.11

Key metrics

Worked out from the statements above. Latest values use fiscal 2025. Valuation uses the share price of $1.34 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Operating margin	-7,001.0%	Operating income / revenue.
EBITDA margin	-6,950.0%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	-7,175.0%	Pre-tax income / revenue.
Net margin	-7,172.0%	Net income / revenue.
FCF margin	-4,070.0%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	-1,961.0%	Cash from operations / revenue.
Return on assets (ROA)	-153.2%	Net income / average total assets.
R&D / revenue	183.2%	Research and development expense / revenue.
Stock-based pay / revenue	370.8%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	2,109.0%	Capital expenditures / revenue.
D&A / revenue	50.9%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	-26.7%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	-37.0%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	-5.8%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	734.4%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	43.0%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	38.1%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	3.4%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	-20.8%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	-6.5%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	0.86x	Current assets / current liabilities.
Quick ratio	0.72x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.66x	(Cash + short-term investments) / current liabilities.
Debt / assets	29.8%	Total debt / total assets.
Liabilities / assets	40.1%	Total liabilities / total assets.
Net debt	$5.4M	Total debt - cash - short-term investments. Negative means more cash than debt.
Interest coverage	-71.9x	Operating income / interest expense.
Working capital	-$1.0M	Current assets - current liabilities.
Goodwill and intangibles / assets	42.5%	(Goodwill + intangible assets) / total assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.02x	Revenue / average total assets.
Fixed asset turnover	0.07x	Revenue / average property, plant and equipment.
Receivables turnover	1.41x	Revenue / average receivables.
Days sales outstanding	259 days	365 x average receivables / revenue.

Per share

Metric	Value	How it is calculated
EPS, diluted	-$0.90	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
EPS, basic	-$0.90	Net income per basic share, as reported (split-adjusted).
Revenue per share	$0.01	Revenue / diluted weighted shares.
FCF per share	-$0.51	Free cash flow / diluted weighted shares.
Operating cash flow per share	-$0.25	Cash from operations / diluted weighted shares.
Cash per share	$0.13	(Cash + short-term investments) / shares outstanding.

Valuation

Metric	Value	How it is calculated
Market cap	$59.2M	Share price x shares outstanding.
Enterprise value	$64.6M	Market cap + total debt - cash - short-term investments.
P/S	144x	Market cap / revenue.
EV/Sales	157x	Enterprise value / revenue.
FCF yield	-28.2%	Free cash flow / market cap.
Earnings yield	-49.8%	Net income / market cap (the inverse of P/E).

What was ABUNDIA GLOBAL IMPACT GROUP, INC.'s revenue in fiscal 2025?

ABUNDIA GLOBAL IMPACT GROUP, INC. reported revenue of $410.6K for fiscal 2025, 26.7% lower than the year before.

Was ABUNDIA GLOBAL IMPACT GROUP, INC. profitable in fiscal 2025?

No. It reported a net loss of $29.5M.

How much free cash flow did ABUNDIA GLOBAL IMPACT GROUP, INC. generate in fiscal 2025?

Cash from operations of $8.1M minus capital expenditures of $8.7M left free cash flow of -$16.7M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to ABUNDIA GLOBAL IMPACT GROUP, INC.